SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is experiencing a sharp decline as investors respond to an underwhelming WWDC presentation, with many community members questioning the company's innovation and its heavy reliance on third-party AI models. While some long-term investors see the pullback as a buying opportunity, others are aggressively rotating into bearish positions, citing the stock's elevated valuation and the lack of a clear, immediate revenue catalyst from the new AI features.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The S&P 500 ETF is seeing extreme volatility as market sentiment shifts rapidly between optimism over a potential Iran ceasefire deal and intense liquidity concerns surrounding the upcoming SpaceX IPO. Investors are actively debating the sustainability of current price levels, with many traders cautioning against complacency while others aggressively play both sides of the sharp intraday swings.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is seeing intense trading activity as investors closely monitor demand for the R2 SUV and its upcoming public deliveries. The community remains deeply divided, with bulls highlighting technological growth and potential new partnerships, while bears continue to focus on the company's long-term path to profitability and high volatility.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as investors digest preliminary May data showing significant double-digit month-over-month growth in its Predictions platform volume. While some community members remain skeptical due to the stock's long-term performance and management's share selling, others are actively debating whether these prediction markets and upcoming major sporting events provide a necessary catalyst for a sustainable breakout.

Keel Infrastructure Corp. engages in building artificial intelligence focused data centers and energy assets. It focuses on infrastructure and energy required to support high-performance computing and artificial intelligence workloads. The company was founded on April 1, 2026 and is headquartered in New York, NY.

Keel Infrastructure Corp.

Keel Infrastructure Corp

Keel Infrastructure Corp is trending as investors speculate on a potential hyperscaler partnership, fueled by an Amazon job posting for a facility in the company's development region. The community remains highly focused on upcoming contract announcements and technical price action, viewing recent volatility as a consolidation phase before potential further upside.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending following the announcement of a new $5.2 billion, 15-year AI data center lease at its fifth campus, an event that has spurred bullish analyst upgrades and renewed investor confidence. The community is actively debating the stock's significant contracted revenue backlog against broader market volatility and algorithmic trading patterns, with many long-term holders viewing current price fluctuations as accumulation opportunities ahead of a potential re-rating.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is experiencing significant volatility as investors weigh a wave of high-profile AI-related IPOs against broader market concerns regarding inflation and geopolitical uncertainty. The community is actively debating whether current price action represents a healthy consolidation or a warning sign of a potential liquidity crunch as capital rotates in anticipation of upcoming mega-cap public debuts.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending as investors anticipate the upcoming earnings report and potential catalysts, including a patent extension for MIPLYFFA and European market expansion. The community is actively discussing the stock's long-term valuation, the strategic significance of recent institutional buying, and the potential for a buyout, while maintaining a watchful eye on technical levels.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors weigh the potential impact of a legal dispute with Nippon Shinyaku against the upcoming PDUFA catalyst for Deramiocel. The community remains largely bullish, focusing on institutional accumulation and the potential for a favorable court resolution to allow for independent commercialization.

Cartesian Growth Corp. III is a blank check company. It was created for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on October 29, 2024 and is headquartered in New York, NY.

Factorial Energy Inc. - Ordinary Shares- Class A

Factorial Energy is experiencing high volatility as the market reacts to its recent SPAC listing and potential for solid-state battery commercialization. The community is actively debating the stock's low-float squeeze potential, ongoing trading halts, and the long-term dilution risks associated with its warrants and operational funding.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

A New $21 Million Position Signals Confidence in This Post-IPO Drug Developer

Key PointsHarbourVest initiated 1,722,210 shares of Generate Biomedicines last quarter; the estimated trade size was $21.03 million based on quarterly average prices...

Generate Biomedicines Inc. to Participate in Goldman Sachs 47th Annual Global Healthcare Conference

Generate Biomedicines Inc. to Participate in Goldman Sachs 47th Annual Global Healthcare Conference Generate Biomedicines Inc. to Participate in Goldman Sachs 47th Annual Global Healthcare Conference PR Newswire SOMERVILLE, Mass., May 28, 2026 SOMERVILLE, Mass., May 28, 2026 /PRNewswire...

Generate Biomedicines, Inc. Reports First Quarter 2026 Financial Results and Provides Business Update

Generate Biomedicines, Inc. Reports First Quarter 2026 Financial Results and Provides Business Update Generate Biomedicines, Inc. Reports First Quarter 2026 Financial Results and Provides Business Update PR Newswire SOMERVILLE, Mass., May 7, 2026 SOLAIRIA-1 AND SOLAIRIA-2 Phase 3 clinical trials...

Generate Biomedicines (NASDAQ:GENB) Hits New 1-Year High  - Should You Buy?

Generate Biomedicines (NASDAQ:GENB) Reaches New 52-Week High - Time to Buy...

Generate Biomedicines (NASDAQ:GENB) Trading Up 8.1% - Should You Buy?

Generate Biomedicines (NASDAQ:GENB) Shares Up 8.1% - Still a Buy...

Generate Biomedicines Inc (NASDAQ:GENB) Given Consensus Rating of "Moderate Buy" by Analysts

Generate Biomedicines Inc (NASDAQ:GENB - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the seven analysts that are covering the stock, Marketbeat Ratings...

Research Analysts Set Expectations for GENB Q1 Earnings

Generate Biomedicines Inc (NASDAQ:GENB - Free Report) - Stock analysts at HC Wainwright issued their Q1 2026 earnings estimates for Generate Biomedicines in a report issued on Monday, April 13th. HC...

Generate Biomedicines (NASDAQ:GENB) Shares Up 7%  - What's Next?

Generate Biomedicines (NASDAQ:GENB) Trading Up 7% - Time to Buy...

Generate Biomedicines (NASDAQ:GENB) Coverage Initiated by Analysts at HC Wainwright

HC Wainwright initiated coverage on Generate Biomedicines in a research note on Monday. They issued a "buy" rating and a $16.00 price objective on the stock...

Generate Biomedicines (NASDAQ:GENB) Trading Down 6.9% - Time to Sell?

Generate Biomedicines (NASDAQ:GENB) Shares Down 6.9% - Time to Sell...

Generate Biomedicines, Inc. is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company was founded in 2018, and is headquartered in Somerville, MA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.51	--	--	N/A
Q1 '26	-$0.51	-$1.07	-110.63%	MISSED

GENBGenerate Biomedicines Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q2 '26

Historical Earnings

Latest GENB News